Dr Reddy's Laboratories (BSP:R1DY34) Cyclically Adjusted Book per Share: R$2.84 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:R1DY34 Dr Reddy's Laboratories Ltd BSP:R1DY34
93 GF Score
Price R$12.10
GF Value R$14.30
! 4 Warning Signs
View Full Analysis

What is Dr Reddy's Laboratories Cyclically Adjusted Book per Share?

Dr Reddy's Laboratories BSP:R1DY34 93 Cyclically Adjusted Book per Share is R$2.84 as of Jun. 2026. GuruFocus rates BSP:R1DY34 with a GF Score™ of 93/100 and a GF Value™ of R$14.30. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dr Reddy's Laboratories's adjusted book value per share for the three months ended in Jun. 2026 was R$4.140. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$2.84 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Dr Reddy's Laboratories's average Cyclically Adjusted Book Growth Rate was 12.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Dr Reddy's Laboratories was 14.20% per year. The lowest was 8.90% per year. And the median was 12.00% per year.

As of today (2026-08-01), Dr Reddy's Laboratories's current stock price is R$12.10. Dr Reddy's Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was R$2.84. Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is 4.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.64.


Dr Reddy's Laboratories  (BSP:R1DY34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.10/2.84
=4.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr Reddy's Laboratories was 6.94. The lowest was 3.25. And the median was 4.64.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Related Terms


Dr Reddy's Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Dr Reddy's Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Chart

Dr Reddy's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 2.08 2.34 2.85 2.74

Dr Reddy's Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.94 2.93 2.67 2.74 2.84

BSP:R1DY34 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Cyclically Adjusted PB Ratio falls into.


BSP:R1DY34
93GF Score
Dr Reddy's Laboratories Ltd BSP:R1DY34
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Reddy's Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr Reddy's Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.14/166.1454*166.1454
=4.140

Current CPI (Jun. 2026) = 166.1454.

Dr Reddy's Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.131 105.961 1.773
201612 1.204 105.196 1.902
201703 1.186 105.196 1.873
201706 1.269 107.109 1.968
201709 1.189 109.021 1.812
201712 1.275 109.404 1.936
201803 1.281 109.786 1.939
201806 1.457 111.317 2.175
201809 1.500 115.142 2.164
201812 1.495 115.142 2.157
201903 1.557 118.202 2.189
201906 1.634 120.880 2.246
201909 1.787 123.175 2.410
201912 1.724 126.235 2.269
202003 2.043 124.705 2.722
202006 2.228 127.000 2.915
202009 2.440 130.118 3.116
202012 2.378 130.889 3.019
202103 2.694 131.771 3.397
202106 2.447 134.084 3.032
202109 2.641 135.847 3.230
202112 2.855 138.161 3.433
202203 2.500 138.822 2.992
202206 2.601 142.347 3.036
202209 2.705 144.661 3.107
202212 2.811 145.763 3.204
202303 2.934 146.865 3.319
202306 2.903 150.280 3.209
202309 3.013 151.492 3.304
202312 3.156 152.924 3.429
202403 3.368 153.035 3.657
202406 3.806 155.789 4.059
202409 4.037 157.882 4.248
202412 4.564 158.323 4.790
202503 4.445 157.552 4.687
202506 4.527 159.755 4.708
202509 4.358 162.289 4.462
202512 4.517 163.281 4.596
202603 4.252 164.272 4.300
202606 4.140 166.145 4.140

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of R$2.84 mean?
Dr Reddy's Laboratories (BSP:R1DY34) has a Cyclically Adjusted Book per Share of R$2.84 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors.
Is Dr Reddy's Laboratories' Cyclically Adjusted Book per Share too high?
Dr Reddy's Laboratories' current Cyclically Adjusted Book per Share is R$2.84. Overall, Dr Reddy's Laboratories has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Dr Reddy's Laboratories' Cyclically Adjusted Book per Share compare to ZTS?
Dr Reddy's Laboratories' Cyclically Adjusted Book per Share of R$2.84 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Dr Reddy's Laboratories and its competitors. Dr Reddy's Laboratories's current Cyclically Adjusted Book per Share is R$2.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Reddy's Laboratories stock overvalued right now?
Dr Reddy's Laboratories (BSP:R1DY34) has a current Cyclically Adjusted Book per Share of R$2.84. The stock's GF Value™ is R$14.30, compared to a current price of R$12.10 — trading 15.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is R$2.84. Dr Reddy's Laboratories' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Dr Reddy's Laboratories (BSP:R1DY34), the current Cyclically Adjusted Book per Share is R$2.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Reddy's Laboratories (BSP:R1DY34) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Reddy's Laboratories stock appears to be undervalued. The current stock price of R$12.10 is trading 15.4% below its estimated GF Value™ of R$14.30.

Key valuation signals for BSP:R1DY34:

  • Cyclically Adjusted Book per Share: R$2.84
  • GF Value™: R$14.30 vs. price of R$12.10 (15.4% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the BSP:R1DY34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr Reddy's Laboratories Business Description

Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
93GF Score

Get the complete analysis for BSP:R1DY34

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$12.10
Price
R$14.30
GF Value